health
Preprint finds lab-evolved resistance mutations align with in vivo data
A bioRxiv preprint reports that ciprofloxacin resistance mutations selected in laboratory experiments largely matched those found in in vivo data for E. coli and P. aeruginosa. The authors say this supports using experimental evolution to help forecast resistance risks, while noting that other bacteria–drug combinations need study.